"Cost-effective" chlamydia tests to cut Danish incidence
This article was originally published in Clinica
Screening couples for chlamydia with home diagnostic kits is likely to be cost effective as long as one partner is first identified as having the disease. This would make it more likely for the second partner to opt to take the home test. This is the conclusion of a recently published report by the Danish Centre for Evaluation and Health Technology Assessment (CEMTV).
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.